Revelation Biosciences Inc (REVB)

Finanzdaten der Revelation Biosciences Inc-Aktie (REVB)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	18.42%3.66	3.09	2.57	1.94	2.46
Research and Development	39.33%1.92	1.38	0.96	0.92	1.32
Operating Income/Loss	18.42%-3.66	-3.09	-2.57	-1.94	-2.46
Net Interest Income/Expense	0.08	-	-	-	-
Nonoperating Income/Loss	306.06%0.34	0.08	0.06	0.04	0.02
	10.45%-3.32	-3.01	-2.51	-1.91	-2.44
Attributable To Parent	10.45%-3.32	-3.01	-2.51	-1.91	-2.44
Available To Common Stockholders, Basic	61.76%-3.32	-8.69	-2.51	-4.68	-5.63
Basic Average Shares	19.38%3.83	3.21	-0.64	2.64	0.80
Diluted Average Shares	19.38%3.83	3.21	-0.64	2.64	0.80
Basic Earnings Per Share	67.90%-0.87	-2.71	-14.19	-1.77	-7.01
Diluted Earnings Per Share	67.90%-0.87	-2.71	-14.19	-1.77	-7.01